Epigenomics AG: Ad hoc Announcement According to #15 WpHG (German Securities Trading Act)
18 nov. 2008 09h44 HE
|
Epigenomics AG
BERLIN, Germany and SEATTLE, Nov. 18, 2008 (GLOBE NEWSWIRE) -- Epigenomics AG (Frankfurt:ECX) (ISIN:DE000A0BVT96) and Abbott Molecular Inc. (Abbott) today have expand their non-exclusive strategic...
Epigenomics AG Reports Q3 and Nine Month 2008 Results
04 nov. 2008 02h52 HE
|
Epigenomics AG
Key Figures (in EUR thousand)
- Revenues: 1,831 in 9M 2008; (9M 2007: 1,809)
- EBIT: -8,536 in 9M 2008; improved by 16% (9M 2007: -10,179)
- Net loss: -8,147 in 9M 2008; reduced by 17% (9M...
Epigenomics AG Reports PRESEPT Clinical Study Progress
27 oct. 2008 04h43 HE
|
Epigenomics AG
-- Successfully qualified 17 PRESEPT clinical sites; 12 sites
initiated
-- Enrollment nearly 500 hundred subjects in first three months
-- Expanded clinical site network to include first...
Epigenomics AG Reports Successful Completion and Positive Results From Prostate Cancer Clinical Study
16 oct. 2008 03h19 HE
|
Epigenomics AG
- Clinical study with patient cohorts from multiple clinical centers
completed
- All study endpoints met
- PITX2 biomarker classifies patients into groups at high and low
risk for...
Epigenomics AG: Voting Rights: Correction Release of a Voting Rights Notification (paragraph 21 Para. 1 WpHG) Released On 11 September 2008 in Accordance With paragraph 26, Para. 1 WpHG (German Securities Trading Act) With the Aim of a Europe-wide Distribution
19 sept. 2008 06h34 HE
|
Epigenomics AG
BERLIN, Sept. 19, 2008 (GLOBE NEWSWIRE) -- Corrected Voting Rights Notification:
In correction of the voting rights notification dated 10 September 2008 and released by Epigenomics AG on 11...
Epigenomics AG: Voting Rights: Publication Pursuant to #26 Sect.1 WpHG (The German Securities Trading Act) With the Aim of Pan-European Distribution
11 sept. 2008 09h26 HE
|
Epigenomics AG
BERLIN, Sept. 11, 2008 (GLOBE NEWSWIRE) -- Voting Rights Notification:
On 10 September 2008 Federated Investors Inc., Pittsburgh, PA, USA made the following notifications regarding the holding of...
Epigenomics Reports Positive Interim Results in Prostate Cancer Clinical Study
08 sept. 2008 03h19 HE
|
Epigenomics AG
-- Clinical study of over 500 patient samples well on track for
completion in Q4 2008
-- Interim analysis representing approximately half of the cases
demonstrates statistical...
Voting Rights: Epigenomics AG: Publication Pursuant to Article 26 Para. 1 WpHG With the Aim of Pan-European Distribution
22 août 2008 05h52 HE
|
Epigenomics AG
BERLIN, Aug. 22, 2008 (GLOBE NEWSWIRE) --
Issuer:
Epigenomics AG
- ISIN DE000A0BVT96 -
Kleine Prasidentenstr. 1
10178 Berlin
Deutschland
Voting Rights Notification:
On 21 August 2008...
Epigenomics AG Reports First Half of 2008 Results
05 août 2008 03h14 HE
|
Epigenomics AG
Key Figures (in EUR thousand)
* Revenues: 1,511 in H1 2008; increased by 13% (H1
2007: 1,343)
* EBIT: -5,888 in H1 2008; improved by 15%
...
Epigenomics AG Receives Allowance for Key Patent in Europe
29 juil. 2008 02h44 HE
|
Epigenomics AG
BERLIN and SEATTLE, July 29, 2008 (PRIME NEWSWIRE) -- Epigenomics AG (Frankfurt Prime Standard:ECX), a molecular diagnostics company focusing on the development and commercialization of products for...